Genomic Health IDs Biomarker Leads for Breast Cancer Recurrence Prognosis via Next-Gen Sequencing

Through the hypothesis-generating exercise, enabled by Illumina's next-generation sequencing platform, the company identified "new candidate biomarkers linked to breast cancer recurrence from regions outside of the previously identified protein-coding sections of the genome."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.